ANLN and clear cell renal carcinoma: In lung, breast, cervical, and clear cell renal cell carcinomas, inhibition of ANLN leads to increased expression of epithelial markers such as E-cadherin and decreased expression of mesenchymal markers including N-cadherin and vimentin, resulting in significantly reduced migration and invasio (Pan et al., 2022; Shan et al., 2025; Wang D. et al., 2020; Xu et al., 2019).